Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1978 2
1979 2
1980 1
1981 2
1984 1
1985 2
1988 1
1989 2
1990 2
1991 3
1992 3
1993 2
1994 2
1995 5
1996 5
1997 6
1998 7
1999 3
2000 6
2001 6
2002 8
2003 11
2004 14
2005 4
2006 8
2007 2
2008 6
2009 7
2010 4
2011 8
2012 4
2013 6
2014 6
2015 6
2016 8
2017 2
2018 2
2019 5
2020 4
2021 9
2022 5
2023 4
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Allergic Rhinitis: A Review.
Bernstein JA, Bernstein JS, Makol R, Ward S. Bernstein JA, et al. JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. JAMA. 2024. PMID: 38470381 Review.
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamine (eg, cetirizine, fexofenadine, desloratadine, loratadine) or an intranasal antihistamine (eg, azelastine, olopatadine), whereas pat …
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamin …
Intranasal triamcinolone and growth velocity.
Skoner DP, Berger WE, Gawchik SM, Akbary A, Qiu C. Skoner DP, et al. Pediatrics. 2015 Feb;135(2):e348-56. doi: 10.1542/peds.2014-1641. Pediatrics. 2015. PMID: 25624374 Clinical Trial.
BACKGROUND: Inadequate designs and conflicting results from previous studies prompted the US Food and Drug Administration to publish guidelines for the design of clinical trials evaluating the effects of orally inhaled and intranasal corticosteroids on the growth of childr …
BACKGROUND: Inadequate designs and conflicting results from previous studies prompted the US Food and Drug Administration to publish guideli …
A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis.
Gawchik SM, Saccar CL. Gawchik SM, et al. Drug Saf. 2000 Oct;23(4):309-22. doi: 10.2165/00002018-200023040-00004. Drug Saf. 2000. PMID: 11051218 Review.
The efficacy of intranasal triamcinolone acetonide in seasonal and allergic rhinitis has been evaluated in clinical trials and has been compared with antihistamines and other intranasal corticosteroids. ...Posterior subcapsular cataract formation has not been …
The efficacy of intranasal triamcinolone acetonide in seasonal and allergic rhinitis has been evaluated in clinical trials and …
Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes.
Bérard A, Sheehy O, Kurzinger ML, Juhaeri J. Bérard A, et al. J Allergy Clin Immunol. 2016 Jul;138(1):97-104.e7. doi: 10.1016/j.jaci.2016.01.021. Epub 2016 Apr 1. J Allergy Clin Immunol. 2016. PMID: 27045580
BACKGROUND: Intranasal corticosteroid use during pregnancy has increased over the past decade. OBJECTIVE: We aim to estimate the safety of intranasal triamcinolone use during pregnancy, which was introduced for over-the-counter use in October 2013. ...CONCLUS …
BACKGROUND: Intranasal corticosteroid use during pregnancy has increased over the past decade. OBJECTIVE: We aim to estimate the safe …
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis.
Soe KK, Krikeerati T, Pheerapanyawaranun C, Niyomnaitham S, Phinyo P, Thongngarm T. Soe KK, et al. Front Pharmacol. 2023 May 23;14:1184552. doi: 10.3389/fphar.2023.1184552. eCollection 2023. Front Pharmacol. 2023. PMID: 37288109 Free PMC article. Review.
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). ...In seasonal AR, mometasone furoate (MF) was ranked the highest efficacy, followed by fluticasone furoate (FF), ciclesonide (CIC), f …
No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis …
Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal in situ gel: formulation and characterization.
Patil R, Patil AS, Chougule K, Gaude Y, Masareddy RS. Patil R, et al. Drug Dev Ind Pharm. 2024 Jan;50(1):68-77. doi: 10.1080/03639045.2023.2297275. Epub 2024 Jan 30. Drug Dev Ind Pharm. 2024. PMID: 38148515
AIM: The primary objective of the research was to develop a cubosomal in situ gel encapsulated with Triamcinolone acetonide (TCA) in order to enhance its penetration through the blood-brain barrier (BBB) when administered via the intranasal route, thus enabling effi …
AIM: The primary objective of the research was to develop a cubosomal in situ gel encapsulated with Triamcinolone acetonide (TCA) in …
Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis.
Bielory L, Gross GN, Letierce A, Melas-Melt L, Lucio L. Bielory L, et al. Ann Allergy Asthma Immunol. 2020 Jun;124(6):616-621.e3. doi: 10.1016/j.anai.2020.01.012. Epub 2020 Jan 28. Ann Allergy Asthma Immunol. 2020. PMID: 32004698 Free article.
In addition to nasal symptoms, up to 75% of sufferers experience itching, redness, and tearing of the eyes. Intranasal corticosteroids are effective in controlling the allergic nasal symptoms, and increasing evidence suggests that they also can relieve some of the allergic …
In addition to nasal symptoms, up to 75% of sufferers experience itching, redness, and tearing of the eyes. Intranasal corticosteroid …
Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
Alhussien AH, Alhedaithy RA, Alsaleh SA. Alhussien AH, et al. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):325-333. doi: 10.1007/s00405-017-4785-3. Epub 2017 Nov 21. Eur Arch Otorhinolaryngol. 2018. PMID: 29164323 Review.
OBJECTIVE: To review the current literature about the safety of intranasal corticosteroid sprays during pregnancy. METHODOLOGY: Using different search engines, each type of INCS was reviewed separately (triamcinolone, beclomethasone, budesonide, fluticasone propiona …
OBJECTIVE: To review the current literature about the safety of intranasal corticosteroid sprays during pregnancy. METHODOLOGY: Using …
193 results